Beyond the inflammasome: Regulatory nod-like receptor modulation of the host immune response following virus exposure

Journal of General Virology

Volumn 97, Issue 4, 2016, Pages 825-838

  Coutermarsh Ott, Sheryl ^a   Eden, Kristin ^a   Allen, Irving Coy ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; ISOPROTEIN; MITOCHONDRIAL PROTEIN; NLRX1 PROTEIN, HUMAN; NOD1 PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY; VIROLOGY; VIRUS;

DEAD BOX PROTEIN 58; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERFERONS; INTERLEUKIN-18; INTERLEUKIN-1BETA; MITOCHONDRIAL PROTEINS; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VIRUS DISEASES; VIRUSES;

EID: 84963764576     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000401     Document Type: Review

References (110)

1. Abbott, D. W., Wilkins, A., Asara, J. M. & Cantley, L. C. (2004). The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 14, 2217–2227.
2. Abdul-Sater, A. A., Saïd-Sadier, N., Lam, V. M., Singh, B., Pettengill, M. A., Soares, F., Tattoli, I., Lipinski, S., Girardin, S. E. & other authors (2010). Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. J Biol Chem 285, 41637–41645.
3. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N. & Tschopp, J. (2004). NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319–325.
4. Allen, I. C., Moore, C. B., Schneider, M., Lei, Y., Davis, B. K., Scull, M. A., Gris, D., Roney, K. E., Zimmermann, A. G. & other authors (2011). NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NFkB signaling pathways. Immunity 34, 854–865.
5. Allen, I. C., Lich, J. D., Arthur, J. C., Jania, C. M., Roberts, R. A., Callaway, J. B., Tilley, S. L. & Ting, J. P. (2012a). Characterization of NLRP12 during the development of allergic airway disease in mice. PLoS One 7, e30612.
6. Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R. M., Davis, B. K., Uronis, J. M. & other authors (2012b). NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kB signaling. Immunity 36, 742–754.
7. Anders, M., Christian, C., McMahon, M., McCormick, F. & Korn, W. M. (2003). Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res 63, 2088–2095.
8. Arnoult, D., Soares, F., Tattoli, I., Castanier, C., Philpott, D. J. & Girardin, S. E. (2009). An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 122, 3161–3168.
9. Arthur, J.C., Lich, J.D., Aziz, R.K., Kotb, M. & Ting, J.P. (2007).Heat shock protein 90 associateswithMonarch-1 and regulates its ability to promote degradation of NF-kB-inducing kinase. J Immunol 179, 6291–6296.
10. Asano, J., Tada, H., Onai, N., Sato, T., Horie, Y., Fujimoto, Y., Fukase, K., Suzuki, A., Mak, T. W. & Ohteki, T. (2010). Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cellmediated cross-priming in vivo. J Immunol 184, 736–745.
11. Askari, N., Correa, R. G., Zhai, D. & Reed, J. C. (2012). Expression, purification, and characterization of recombinant NOD1 (NLRC1): a NLR family member. J Biotechnol 157, 75–81.
12. Benko, S., Magalhaes, J. G., Philpott, D. J. & Girardin, S. E. (2010). NLRC5 limits the activation of inflammatory pathways. J Immunol 185, 1681–1691.
13. Bortoluci, K. R. & Medzhitov, R. (2010). Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol Life Sci 67, 1643–1651.
14. Broz, P. & Monack, D. M. (2013). Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 13, 551–565.
15. Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y. & Vance, R. E. (2011). STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515–518.
16. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K. & other authors (2003). An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid.Nat Immunol 4, 702–707.
17. Collins, S. J., Robertson, K. A. & Mueller, L. (1990). Retinoic acidinduced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-a). Mol Cell Biol 10, 2154–2163.
18. Conti, B. J., Davis, B. K., Zhang, J., O’connor, W., Jr, Williams, K. L. & Ting, J. P. (2005). CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function. J Biol Chem 280, 18375–18385.
19. da Silva Correia, J., Miranda, Y., Leonard, N. & Ulevitch, R. (2007). SGT1 is essential for Nod1 activation. Proc Natl Acad Sci U S A 104, 6764–6769.
20. Davis, B. K., Roberts, R. A., Huang, M. T., Willingham, S. B., Conti, B. J., Brickey, W. J., Barker, B. R., Kwan, M., Taxman, D. J. & other authors (2011). Cutting edge: NLRC5-dependent activation of the inflammasome. J Immunol 186, 1333–1337.
21. Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513.
22. Ferwerda, G., Girardin, S. E., Kullberg, B. J., Le Bourhis, L., de Jong, D. J., Langenberg, D. M., van Crevel, R., Adema, G. J., Ottenhoff, T. H. & other authors (2005). NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 1, 279–285.
23. Girardin, S. E., Tournebize, R., Mavris, M., Page, A. L., Li, X., Stark, G. R., Bertin, J., DiStefano, P. S., Yaniv, M. & other authors (2001). CARD4/Nod1 mediates NF-kB and JNK activation by invasive Shigella flexneri. EMBO Rep 2, 736–742.
24. Hasegawa, M., Fujimoto, Y., Lucas, P. C., Nakano, H., Fukase, K., Núñez, G. & Inohara, N. (2008). A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kB activation. EMBO J 27, 373–383.
25. Hisamatsu, T., Suzuki, M., Reinecker, H. C., Nadeau, W. J., McCormick, B. A. & Podolsky, D. K. (2003). CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993–1000.
26. Hong, M., Yoon, S. I. & Wilson, I. A. (2012). Structure and functional characterization of the RNA-binding element of the NLRX1 innate immune modulator. Immunity 36, 337–347.
27. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E. & Fitzgerald, K. A. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518.
28. Hruz, P. & Eckmann, L. (2011). Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease. Swiss Med Wkly 140, w13135.
29. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J. P., Belaiche, J., Almer, S., Tysk, C., O’Morain, C. A. & other authors (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603.
30. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S. & other authors (2003). Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 278, 5509–5512.
31. Ishikawa, H. & Barber, G. N. (2008). STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678.
32. Ishikawa, H., Ma, Z. & Barber, G. N. (2009). STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792.
33. Jaworska, J., Coulombe, F., Downey, J., Tzelepis, F., Shalaby, K., Tattoli, I., Berube, J., Rousseau, S., Martin, J. G. & other authors (2014). NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proc Natl Acad Sci USA 111, E2110–E2119.
34. Jin, J., Hu, H., Li, H. S., Yu, J., Xiao, Y., Brittain, G. C., Zou, Q., Cheng, X., Mallette, F. A. & other authors (2014). Noncanonical NF-kB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 40, 342–354.
35. Jing, H., Fang, L., Wang, D., Ding, Z., Luo, R., Chen, H. & Xiao, S. (2014). Porcine reproductive and respiratory syndrome virus infection activates NOD2-RIP2 signal pathway in MARC-145 cells. Virology 458-459, 162–171.
36. Kang, M. J., Yoon, C. M., Kim, B. H., Lee, C. M., Zhou, Y., Sauler, M., Homer, R., Dhamija, A., Boffa, D. & other authors (2015). Suppression of NLRX1 in chronic obstructive pulmonary disease. J Clin Invest 125, 2458–2462.
37. Kapoor, A., Forman, M. & Arav-Boger, R. (2014). Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. PLoS One 9, e92704.
38. Keestra, A. M. & Bäumler, A. J. (2014). Detection of enteric pathogens by the nodosome. Trends Immunol 35, 123–130.
39. Kim, J. G., Lee, S. J. & Kagnoff, M. F. (2004). Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect Immun 72, 1487–1495.
40. Kim, J. J., Simpson, N., Klipfel, N., Debose, R., Barr, N. & Laine, L. (2010). Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 55, 1059–1065.
41. Kim, Y. G., Park, J. H., Reimer, T., Baker, D. P., Kawai, T., Kumar, H., Akira, S., Wobus, C. & Núñez, G. (2011). Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9, 496–507.
42. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Núñez, G. & Flavell, R. A. (2005). Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734.
43. Krieg, A., Correa, R. G., Garrison, J. B., Le Negrate, G., Welsh, K., Huang, Z., Knoefel, W. T. & Reed, J. C. (2009). XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A 106, 14524–14529.
44. Kufer, T. A., Kremmer, E., Adam, A. C., Philpott, D. J. & Sansonetti, P. J. (2008). The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 10, 477–486.
45. Lee, Y. H., Chiu, Y. F., Wang, W. H., Chang, L. K. & Liu, S. T. (2008). Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta. J Gen Virol 89, 2437–2446.
46. Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K. W., Damania, B. & other authors (2012). The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 36, 933–946.
47. Lei, Y., Wen, H. & Ting, J. P. (2013). The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy 9, 432–433.
48. Lich, J. D., Williams, K. L., Moore, C. B., Arthur, J. C., Davis, B. K., Taxman, D. J. & Ting, J. P. (2007). Monarch-1 suppresses noncanonical NF-kB activation and p52-dependent chemokine expression in monocytes. J Immunol 178, 1256–1260.
49. Liu, P., Li, K., Garofalo, R. P. & Brasier, A. R. (2008). Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kB2 complexes via a novel retinoic acid-inducible gene-I?NFkB- inducing kinase signaling pathway. J Biol Chem 283, 23169–23178.
50. Lupfer, C. & Kanneganti, T. D. (2013). Unsolved mysteries in NLR biology. Front Immunol 4, 285.
51. +T cell responses to influenza A virus infection. J Virol 88, 8946–8955.
52. Magalhaes, J. G., Fritz, J. H., Le Bourhis, L., Sellge, G., Travassos, L. H., Selvanantham, T., Girardin, S. E., Gommerman, J. L. & Philpott, D. J. (2008). Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol 181, 7925–7935.
53. Mangan, M. S. & Latz, E. (2014). NLRC3 puts the brakes on STING. Immunity 40, 305–306.
54. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. & Dixit, V. M. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213–218.
55. Martinon, F. & Tschopp, J. (2005). NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26, 447–454.
56. Martinon, F., Burns, K. & Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 10, 417–426.
57. Mason, D. R., Beck, P. L. & Muruve, D. A. (2012). Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J Innate Immun 4, 16–30.
58. Matsuoka, K., Iwao, Y., Mori, T., Sakuraba, A., Yajima, T., Hisamatsu, T., Okamoto, S., Morohoshi, Y., Izumiya, M. & other authors (2007). Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 102, 331–337.
59. Meissner, T.B., Li, A., Biswas, A., Lee, K. H., Liu, Y. J., Bayir, E., Iliopoulos, D., van den Elsen, P. J. & Kobayashi, K. S. (2010). NLR family member NLRC5 is a transcriptional regulator ofMHCclass I genes. ProcNatl Acad Sci U S A 107, 13794–13799.
60. Miao, E. A., Leaf, I. A., Treuting, P. M., Mao, D. P., Dors, M., Sarkar, A., Warren, S. E., Wewers, M. D. & Aderem, A. (2010). Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11, 1136–1142.
61. Mo, J., Boyle, J. P., Howard, C. B., Monie, T. P., Davis, B. K. & Duncan, J. A. (2012). Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J Biol Chem 287, 23057–23067.
62. Moore, C. B., Bergstralh, D. T., Duncan, J. A., Lei, Y., Morrison, T. E., Zimmermann, A. G., Accavitti-Loper, M. A., Madden, V. J., Sun, L. & other authors (2008). NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451, 573–577.
63. Moreira, L. O., Smith, A. M., DeFreitas, A. A., Qualls, J. E., El Kasmi, K. C. & Murray, P. J. (2008). Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2. Vaccine 26, 5808–5813.
64. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R. & other authors (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411, 603–606.
65. Opitz, B., Püschel, A., Schmeck, B., Hocke, A. C., Rosseau, S., Hammerschmidt, S., Schumann, R. R., Suttorp, N. & Hippenstiel, S. (2004). Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279, 36426–36432.
66. Opitz, B., Förster, S., Hocke, A.C., Maass, M., Schmeck, B., Hippenstiel, S., Suttorp, N. & Krüll, M. (2005). Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96, 319–326.
67. Orlandi, C., Forlani, G., Tosi, G. & Accolla, R. S. (2011). Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication. J Transl Med 9, 106.
68. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U. R. & Ludwig, S. (2001). Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 3, 301–305.
69. Popik, W., Hesselgesser, J. E. & Pitha, P. M. (1998). Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 72, 6406–6413.
70. Rosenstiel, P., Fantini, M., Bräutigam, K., Kühbacher, T., Waetzig, G. H., Seegert, D. & Schreiber, S. (2003). TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001–1009.
71. Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y. & Bose, S. (2009). Activation of innate immune antiviral responses by Nod2. Nat Immunol 10, 1073–1080.
72. Sang, Y., Ross, C. R., Rowland, R. R. & Blecha, F. (2008). Toll-like receptor 3 activation decreases porcine arterivirus infection. Viral Immunol 21, 303–314.
73. Schneider, M., Zimmermann, A. G., Roberts, R. A., Zhang, L., Swanson, K. V., Wen, H., Davis, B. K., Allen, I. C., Holl, E. K. & other authors (2012). The innate immune sensor NLRC3 attenuates Tolllike receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kB. Nat Immunol 13, 823–831.
74. Schroder, K. & Tschopp, J. (2010). The inflammasomes. Cell 140, 821–832.
75. Schwarz, K. B. (1996). Oxidative stress during viral infection: a review. Free Radic Biol Med 21, 641–649.
76. Senft, A. P., Taylor, R. H., Lei, W., Campbell, S. A., Tipper, J. L., Martinez, M. J., Witt, T. L., Clay, C. C. & Harrod, K. S. (2010). Respiratory syncytial virus impairs macrophage IFN-α/β- and IFN-γ-stimulated transcription by distinct mechanisms. Am J Respir Cell Mol Biol 42, 404–414.
77. Shoji-Kawata, S. & Levine, B. (2009). Autophagy, antiviral immunity, and viral countermeasures. Biochim Biophys Acta 1793, 1478–1484.
78. Silveira, T. N. & Zamboni, D. S. (2010). Pore formation triggered by Legionella spp. is an Nlrc4 inflammasome-dependent host cell response that precedes pyroptosis. Infect Immun 78, 1403–1413.
79. Singh, K., Poteryakhina, A., Zheltukhin, A., Bhatelia, K., Prajapati, P., Sripada, L., Tomar, D., Singh, R., Singh, A. K. & other authors (2015). NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells. Biochim Biophys Acta 1853, 1073–1086.
80. Soares, F., Tattoli, I., Wortzman, M. E., Arnoult, D., Philpott, D. J. & Girardin, S. E. (2013). NLRX1 does not inhibit MAVS-dependent antiviral signalling. Innate Immun 19, 438–448.
81. Soares, F., Tattoli, I., Rahman, M. A., Robertson, S. J., Belcheva, A., Liu, D., Streutker, C., Winer, S., Winer, D. A. & other authors (2014). The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis. J Biol Chem 289, 19317–19330.
82. +T cell death pathways ex vivo. Retrovirology 11, 14.
83. Strober, W., Murray, P. J., Kitani, A. & Watanabe, T. (2006). Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 6, 9–20.
84. Tada, H., Aiba, S., Shibata, K., Ohteki, T. & Takada, H. (2005). Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin- 12 and T helper type 1 cells. Infect Immun 73, 7967–7976.
85. Tattoli, I., Travassos, L. H., Carneiro, L. A., Magalhaes, J. G. & Girardin, S. E. (2007). The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol 29, 289–301.
86. Tattoli, I., Carneiro, L. A., Jéhanno, M., Magalhaes, J. G., Shu, Y., Philpott, D. J., Arnoult, D. & Girardin, S. E. (2008). NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kB and JNK pathways by inducing reactive oxygen species production. EMBO Rep 9, 293–300.
87. Tosi, G., Forlani, G., Andresen, V., Turci, M., Bertazzoni, U., Franchini, G., Poli, G. & Accolla, R. S. (2011). Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication. J Virol 85, 10719–10729.
88. Travassos, L. H., Carneiro, L. A., Girardin, S. E., Boneca, I. G., Lemos, R., Bozza, M. T., Domingues, R. C., Coyle, A. J., Bertin, J. & other authors (2005). Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem 280, 36714–36718.
89. Travassos, L. H., Carneiro, L. A., Girardin, S. & Philpott, D. J. (2010a). Nod proteins link bacterial sensing and autophagy. Autophagy 6, 409–411.
90. Travassos, L. H., Carneiro, L. A., Ramjeet, M., Hussey, S., Kim, Y. G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E. & other authors (2010b). Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11, 55–62.
91. Tsuchiya, K., Hara, H., Kawamura, I., Nomura, T., Yamamoto, T., Daim, S., Dewamitta, S. R., Shen, Y., Fang, R. & Mitsuyama, M. (2010). Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol 185, 1186–1195.
92. Tuncer, S., Fiorillo, M. T. & Sorrentino, R. (2014). The multifaceted nature of NLRP12. J Leukoc Biol 96, 991–1000.
93. Unger, B. L., Ganesan, S., Comstock, A. T., Faris, A. N., Hershenson, M. B. & Sajjan, U. S. (2014). Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells. J Virol 88, 3705–3718.
94. Van Gorp, H., Kuchmiy, A., Van Hauwermeiren, F. & Lamkanfi, M. (2014). NOD-like receptors interfacing the immune and reproductive systems. FEBS J 281, 4568–4582.
95. Vissers, M., Remijn, T., Oosting, M., de Jong, D. J., Diavatopoulos, D. A., Hermans, P. W. & Ferwerda, G. (2012). Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells. Eur J Immunol 42, 2727–2735.
96. Wagner, R. N., Proell, M., Kufer, T. A. & Schwarzenbacher, R. (2009). Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS One 4, e4931.
97. Watanabe, T., Kitani, A., Murray, P. J. & Strober, W. (2004). NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5, 800–808.
98. Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A. & Strober, W. (2010). NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest 120, 1645–1662.
99. Watanabe, T., Asano, N., Kitani, A., Fuss, I. J., Chiba, T. & Strober, W. (2011). Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection. Gut Microbes 2, 61–65.
100. Wlodarska, M., Thaiss, C. A., Nowarski, R., Henao-Mejia, J., Zhang, J. P., Brown, E. M., Frankel, G., Levy, M., Katz, M. N. & other authors (2014). NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045–1059.
101. Xia, X., Cui, J., Wang, H. Y., Zhu, L., Matsueda, S., Wang, Q., Yang, X., Hong, J., Songyang, Z. & other authors (2011). NLRX1 negatively regulates TLR-induced NF-kB signaling by targeting TRAF6 and IKK. Immunity 34, 843–853.
102. Yang, X. & Gabuzda, D. (1999). Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogenactivated protein kinase signaling pathway. J Virol 73, 3460–3466.
103. Ye, Z. & Ting, J. P. (2008). NLR, the nucleotide-binding domain leucinerich repeat containing gene family. Curr Opin Immunol 20, 3–9.
104. Yeretssian, G., Correa, R. G., Doiron, K., Fitzgerald, P., Dillon, C. P., Green, D. R., Reed, J. C. & Saleh, M. (2011). Non-apoptotic role of BID in inflammation and innate immunity. Nature 474, 96–99.
105. Zaki, M. H., Vogel, P., Malireddi, R. K., Body-Malapel, M., Anand, P. K., Bertin, J., Green, D. R., Lamkanfi, M. & Kanneganti, T. D. (2011). The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20, 649–660.
106. Zaki, M. H., Man, S. M., Vogel, P., Lamkanfi, M. & Kanneganti, T. D. (2014). Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection. Proc Natl Acad Sci U S A 111, 385–390.
107. Zhang, L., Mo, J., Swanson, K. V., Wen, H., Petrucelli, A., Gregory, S. M., Zhang, Z., Schneider, M., Jiang, Y. & other authors (2014). NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 40, 329–341.
108. Zhao, L. J., Wang, L., Ren, H., Cao, J., Li, L., Ke, J. S. & Qi, Z. T. (2005). Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp Cell Res 305, 23–32.
109. Zhao, L. J., Zhang, X. L., Zhao, P., Cao, J., Cao, M. M., Zhu, S. Y., Liu, H. Q. & Qi, Z. T. (2006). Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J Leukoc Biol 80, 424–432.
110. Zhao, L. J., Wang, W., Ren, H. & Qi, Z. T. (2013). ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN. Cell Stress Chaperones 18, 495–501.